These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 28388957)

  • 1. HBXIP overexpression is correlated with the clinical features and survival outcome of ovarian cancer.
    Wang Y; Sun J; Li N; Che S; Jin T; Liu S; Lin Z
    J Ovarian Res; 2017 Apr; 10(1):26. PubMed ID: 28388957
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HBXIP suppression reduces cell proliferation and migration and its overexpression predicts poor prognosis in non-small-cell lung cancer.
    Wang Y; Li N; Che S; Jin T; Piao J; Liu S; Lin Z
    Tumour Biol; 2017 Jul; 39(7):1010428317709675. PubMed ID: 28718367
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HBXIP expression predicts patient prognosis in breast cancer.
    Cheng D; Liang B; Li Y
    Med Oncol; 2014 Oct; 31(10):210. PubMed ID: 25178941
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HBXIP over expression as an independent biomarker for cervical cancer.
    Li N; Wang Y; Che S; Yang Y; Piao J; Liu S; Lin Z
    Exp Mol Pathol; 2017 Feb; 102(1):133-137. PubMed ID: 28093193
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [HBXIP expression in gastric adenocarcinoma predicts poor prognosis].
    Piao JJ; Li N; Wang YX; Lin ZH; Liu SP
    Zhonghua Bing Li Xue Za Zhi; 2017 Feb; 46(2):88-92. PubMed ID: 28173666
    [No Abstract]   [Full Text] [Related]  

  • 6. HBXIP protein overexpression predicts the poor prognosis of pancreatic ductal adenocarcinomas.
    Zhou X; Wang X; Duan J; Sun W; Chen Z; Li Q; Ou Z; Jiang G; Ren X; Liu S
    Pathol Res Pract; 2019 Feb; 215(2):343-346. PubMed ID: 30583814
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The expression of DBC1/CCAR2 is associated with poor prognosis of ovarian carcinoma.
    Cho D; Park H; Park SH; Kim K; Chung M; Moon W; Kang M; Jang K
    J Ovarian Res; 2015 Feb; 8():2. PubMed ID: 25823848
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinicopathological implications of Tiam1 overexpression in invasive ductal carcinoma of the breast.
    Li Z; Liu Q; Piao J; Hua F; Wang J; Jin G; Lin Z; Zhang Y
    BMC Cancer; 2016 Aug; 16(1):681. PubMed ID: 27562113
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NQO1 protein expression predicts poor prognosis of non-small cell lung cancers.
    Li Z; Zhang Y; Jin T; Men J; Lin Z; Qi P; Piao Y; Yan G
    BMC Cancer; 2015 Mar; 15():207. PubMed ID: 25880877
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elevated HBXIP expression is associated with aggressive phenotype and poor prognosis in esophageal squamous cell carcinoma.
    Xia H; Ma L; Li J; Bai H; Wang D
    Am J Cancer Res; 2017; 7(11):2190-2198. PubMed ID: 29218243
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The clinicopathological significance of Mortalin overexpression in invasive ductal carcinoma of breast.
    Jin H; Ji M; Chen L; Liu Q; Che S; Xu M; Lin Z
    J Exp Clin Cancer Res; 2016 Mar; 35():42. PubMed ID: 26955804
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The oncoprotein hepatitis B X-interacting protein promotes the migration of ovarian cancer cells through the upregulation of S-phase kinase-associated protein 2 by Sp1.
    Xu F; Zhu X; Han T; You X; Liu F; Ye L; Zhang X; Wang X; Yao Y
    Int J Oncol; 2014 Jul; 45(1):255-63. PubMed ID: 24788380
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High expression of NQO1 is associated with poor prognosis in serous ovarian carcinoma.
    Cui X; Li L; Yan G; Meng K; Lin Z; Nan Y; Jin G; Li C
    BMC Cancer; 2015 Apr; 15():244. PubMed ID: 25885439
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High HBXIP expression is related to poor prognosis in HCC by extensive database interrogation.
    Guo ZY; Jiang LP; Zhu ZT
    Eur Rev Med Pharmacol Sci; 2021 Oct; 25(20):6196-6207. PubMed ID: 34730200
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HBXIP: a potential prognosis biomarker of colorectal cancer which promotes invasion and migration via epithelial-mesenchymal transition.
    Wang X; Feng Q; Yu H; Zhou X; Shan C; Zhang Q; Liu S
    Life Sci; 2020 Mar; 245():117354. PubMed ID: 31987874
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overexpression of the recently identified oncogene REDD1 correlates with tumor progression and is an independent unfavorable prognostic factor for ovarian carcinoma.
    Chang B; Meng J; Zhu H; Du X; Sun L; Wang L; Li S; Yang G
    Diagn Pathol; 2018 Nov; 13(1):87. PubMed ID: 30428884
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overexpression of Siah2 Is Associated With Poor Prognosis in Patients With Epithelial Ovarian Carcinoma.
    Gao Y; Liu Y; Meng F; Shang P; Wang S; Zhang Y; Sun Y; Wang Y; Wang J; Chen X
    Int J Gynecol Cancer; 2016 Jan; 26(1):114-9. PubMed ID: 26512788
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Upregulation of Abelson interactor protein 1 predicts tumor progression and poor outcome in epithelial ovarian cancer.
    Zhang J; Tang L; Chen Y; Duan Z; Xiao L; Li W; Liu X; Shen L
    Hum Pathol; 2015 Sep; 46(9):1331-40. PubMed ID: 26193797
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The mTOR downstream regulator (p-4EBP1) is a novel independent prognostic marker in ovarian cancer.
    Alabdullah ML; Ahmad DA; Moseley P; Madhusudan S; Chan S; Rakha E
    J Obstet Gynaecol; 2019 May; 39(4):522-528. PubMed ID: 30712414
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mortalin overexpression predicts poor prognosis in early stage of non-small cell lung cancer.
    Sun J; Che SL; Piao JJ; Xu M; Chen LY; Lin ZH
    Tumour Biol; 2017 Mar; 39(3):1010428317695918. PubMed ID: 28349826
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.